Cargando…

Recent Trends and In-Hospital Mortality of Transarterial Chemoembolization (TACE) in Germany: A Systematic Analysis of Hospital Discharge Data between 2010 and 2019

SIMPLE SUMMARY: The minimally invasive procedure of transarterial chemoembolization (TACE) represents a standard oncologic procedure for the treatment of intermediate-stage hepatocellular carcinoma, cholangiocarcinoma, and liver metastases. Up to now, comprehensive data on recent trends and post-int...

Descripción completa

Detalles Bibliográficos
Autores principales:	Krieg, Sarah, Essing, Tobias, Krieg, Andreas, Roderburg, Christoph, Luedde, Tom, Loosen, Sven H.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9100764/ https://www.ncbi.nlm.nih.gov/pubmed/35565218 http://dx.doi.org/10.3390/cancers14092088

Ejemplares similares

Current Trends in Inpatient Care and In-Hospital Mortality of Cholangiocarcinoma in Germany: A Systematic Analysis between 2010 and 2019
por: Roderburg, Christoph, et al.
Publicado: (2022)

Sarcopenia indicate poor survival in patients undergoing transarterial chemoembolization (TACE) for hepatic malignancies
por: Loosen, Sven H., et al.
Publicado: (2023)

Sarcopenia Is a Negative Prognostic Factor in Patients Undergoing Transarterial Chemoembolization (TACE) for Hepatic Malignancies
por: Loosen, Sven H., et al.
Publicado: (2019)

The association between the body height and cardiovascular diseases: a retrospective analysis of 657,310 outpatients in Germany
por: Krieg, Sarah, et al.
Publicado: (2022)

Selective internal radiotherapy in Germany: a review of indications and hospital mortality from 2012 to 2019
por: Mertens, Alexander, et al.
Publicado: (2023)

The Association between Infectious Mononucleosis and Cancer: A Cohort Study of 24,190 Outpatients in Germany
por: Roderburg, Christoph, et al.
Publicado: (2022)

The association between body height and cancer: a retrospective analysis of 784,192 outpatients in Germany
por: Krieg, Sarah, et al.
Publicado: (2022)

Adult Body Height Is Associated with the Risk of Type 2 but Not Type 1 Diabetes Mellitus: A Retrospective Cohort Study of 783,029 Individuals in Germany
por: Loosen, Sven H., et al.
Publicado: (2023)

The Landscape of Outpatient Palliative Care in Germany: Results from a Retrospective Analysis of 14,792 Patients
por: Loosen, Sven H., et al.
Publicado: (2022)

Drug landscape in patients receiving general outpatient palliative care in Germany: results from a retrospective analysis of 10,464 patients
por: Loosen, Sven H., et al.
Publicado: (2023)

Non-alcoholic fatty liver disease (NAFLD) is associated with an increased incidence of chronic kidney disease (CKD)
por: Roderburg, Christoph, et al.
Publicado: (2023)

The Association between Antibiotic Use and the Incidence of Heart Failure: A Retrospective Case-Control Study of 162,188 Outpatients
por: Loosen, Sven H., et al.
Publicado: (2023)

Are sleep disorders associated with the risk of gastrointestinal cancer?—A case–control study
por: Loosen, Sven, et al.
Publicado: (2023)

Analyses of sex-based clinicopathological differences among patients with gastrointestinal neuroendocrine neoplasms in Europe
por: Jann, Henning, et al.
Publicado: (2023)

Transarterial Chemoembolization of Child-A hepatocellular carcinoma: Drug-eluting bead TACE (DEB TACE) vs. TACE with Cisplatin/Lipiodol (cTACE)
por: Wiggermann, Philipp, et al.
Publicado: (2011)

Transarterial chemoembolization (TACE) plus sorafenib: a real winning combination?
por: Adhoute, Xavier, et al.
Publicado: (2020)

Clinical characteristics of 662 patients with pancreatic neuroendocrine tumors receiving antitumoral therapy
por: Loosen, Sven H., et al.
Publicado: (2022)

Prediction of New-Onset Diabetes Mellitus within 12 Months after Liver Transplantation—A Machine Learning Approach
por: Loosen, Sven H., et al.
Publicado: (2023)

Non-Alcoholic Fatty Liver Disease (NAFLD) and risk of new-onset heart failure: a retrospective analysis of 173,966 patients
por: Roderburg, Christoph, et al.
Publicado: (2023)

A New Nomogram-Based Prediction Model for Postoperative Outcome after Sigmoid Resection for Diverticular Disease
por: Vaghiri, Sascha, et al.
Publicado: (2023)

Transarterial Chemoembolization (TACE) Plus Sorafenib Compared to TACE Alone in Transplant Recipients with Hepatocellular Carcinoma: An Institution Experience
por: Abdelrahim, Maen, et al.
Publicado: (2022)

Macrophage migration inhibitory factor predicts an unfavorable outcome after transarterial chemoembolization for hepatic malignancies
por: Wirtz, Theresa H., et al.
Publicado: (2021)

A review of applying transarterial chemoembolization (TACE) method for management of hepatocellular carcinoma
por: Ghanaati, Hossein, et al.
Publicado: (2021)

Transarterial Chemoembolization (TACE) plus Sorafenib Versus TACE for Intermediate or Advanced Stage Hepatocellular Carcinoma: A Meta-Analysis
por: Zhang, Leida, et al.
Publicado: (2014)

Diffuse Recurrence of Hepatocellular Carcinoma After Liver Resection: Transarterial Chemoembolization (TACE) Combined With Sorafenib Versus TACE Monotherapy
por: Yao, Wang, et al.
Publicado: (2020)

Impact of the COVID-19 Pandemic on Consultations and Diagnoses in Gastroenterology Practices in Germany
por: Jördens, Markus S., et al.
Publicado: (2021)

Outcome of conventional transarterial chemoembolization (cTACE) in the management of spontaneously ruptured hepatocellular carcinoma
por: Patidar, Yashwant, et al.
Publicado: (2019)

Transarterial Chemoembolization (TACE) Combined with Sorafenib versus TACE Alone for Unresectable Hepatocellular Carcinoma: A Propensity Score Matching Study
por: Ren, Baosheng, et al.
Publicado: (2019)

Achalasia is associated with a higher incidence of depression in outpatients in Germany
por: Loosen, Sven H., et al.
Publicado: (2021)

Transarterial chemoembolization (TACE) combined with apatinib versus TACE combined with sorafenib in advanced hepatocellular carcinoma patients: a multicenter retrospective study
por: Qiu, Zhiyu, et al.
Publicado: (2021)

Transarterial chemoembolization (TACE) plus tyrosine kinase inhibitors versus TACE in patients with hepatocellular carcinoma: a systematic review and meta-analysis
por: Duan, Ruihua, et al.
Publicado: (2023)

A retrospective study of transarterial chemoembolization (TACE) combined with lenvatinib compared with TACE monotherapy for BCLC B2 stage hepatocellular carcinoma
por: Liu, Junning, et al.
Publicado: (2023)

Drug-eluting microspheres transarterial chemoembolization (DEM TACE) in patients with liver metastases. Pilot study
por: Jarząbek, Magdalena, et al.
Publicado: (2011)

Identifying optimal candidates of transarterial chemoembolization (TACE) vs. sorafenib in patients with unresectable hepatocellular carcinoma
por: Zhao, Shoujie, et al.
Publicado: (2020)

Efficacy and safety of apatinib combined with transarterial chemoembolization (TACE) in treating patients with recurrent hepatocellular carcinoma
por: Gu, Huiying, et al.
Publicado: (2020)

Distribution of gastrointestinal neuroendocrine tumors in Europe: results from a retrospective cross-sectional study
por: Loosen, Sven H., et al.
Publicado: (2022)

Elevated soluble urokinase plasminogen activator receptor serum levels indicate poor survival following transarterial chemoembolization therapy for hepatic malignancies: An exploratory analysis
por: Loosen, Sven H, et al.
Publicado: (2021)

Herpes zoster is not associated with subsequent gastrointestinal cancer: data from over 200,000 outpatients in Germany
por: Leyh, Catherine, et al.
Publicado: (2023)

Transarterial chemoembolization (TACE) combined with sorafenib versus TACE for hepatocellular carcinoma with portal vein tumor thrombus: a systematic review and meta-analysis
por: Zhang, XiuPing, et al.
Publicado: (2017)

Initial Transarterial Chemoembolization (TACE) Using HepaSpheres 20–40 µm and Subsequent Lipiodol TACE in Patients with Hepatocellular Carcinoma > 5 cm
por: Cho, Su Min, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_cimnfq9gji7erfeh5bqeso93bf